Cardiovascular risk in patients with bipolar disorder

Journal of Affective Disorders

Volumn 115, Issue 3, 2009, Pages 302-308

  Garcia Portilla, Maria P ^a,b   Saiz, Pilar A ^a,b   Bascaran, Maria T ^a,b   Martíneza, Sara ^b   Benabarre, Antonio ^b,c   Sierra, Pilar ^d   Torres, Pedro ^e   Montes, Jose Manuel ^b,f   Bousoño, Manuel ^a,b   Bobes, Julio ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e Hospital Complex Jaen   (Spain)

^f UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Bipolar disorder; Cardiovascular risk; Framinghan function; SCORE function

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; METABOLIC SYNDROME X; MORTALITY; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SEX DIFFERENCE; SMOKING;

ADULT; AGING; BIPOLAR DISORDER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING; SPAIN; TIME FACTORS;

EID: 67349118778     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.09.008     Document Type: Article

References (29)

1. Ahrens B., Müller-Oerlinghausen B., Schou M., Wolf T., Alda M., Grof E., Grof P., Lenz G., Simhandl C., Thau K., Vestergaard P., Wolf R., and Möller H.J. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium profilaxis. J. Affect. Disord. 33 (1995) 67-75
2. Angst F., Stassen H.H., Clayton P.J., and Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J. Affect. Disord. 68 (2002) 167-181
3. Aranceta J., et al., Grupo Colaborativo para el estudio DORICA fase II. Tablas de evolución del riesgo coronario adaptadas a la población española. Estudio DORICA. Med. Clin. (Barc.) 123 (2004) 686-691
4. Birkenaes A.B., Opjordsmoen S., Brunborg C., Engh J.A., Jonsdottir H., Ringen P.A., Simonsen C., Vaskinn A., Birkeland K.I., Friis S., Sundet K., and Andreassen O.A. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J. Clin. Psyhiatry 68 (2007) 917-923
5. Bobes J., et al., on behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr. Res. 90 (2007) 162-173
6. Bobes, J., et al., on behalf of the Consensus Group of Experts on Physical Health in Patients with Bipolar Disorders, 2008. Spanish Consensus on Physical Health of Patients with Bipolar Disorder. Revista de Psiquiatría y Salud Mental 1, 26-37.
7. Brodersen A., Licht R.W., Vestergaard P., Olesen A.V., and Mortensen P.B. Sixteen-year mortality in patients with affective disorder commenced on lithium. Br. J. Psychiatry 176 (2000) 429-433
8. Cardenas J., Frye M.A., Marusak S.L., Levander E.M., Chirichigno J.W., Lewis S., Nakelsky S., Hwang S., Mintz J., and Altshuler L.L. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J. Affect. Disord. 106 (2008) 91-97
9. Conroy R.M., et al., SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 24 (2003) 987-1003
10. Correll C.U., Frederickson A.M., Kane J.M., and Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord. 10 (2008) 1-10
11. De Baker G., Ambrosini E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., Ebrahim S., Faergeman O., Graham I., Mancia G., Manger Cats V., Orth-Gomer K., Perk J., Pyorala K., Rodicio J.L., Sans S., Sansoy V., Sechtem U., Silber S., Thomsen T., and Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 24 (2003) 1601-1610
12. Empana J.P., et al., PRIME Study Group. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur. Heart J. 24 (2003) 1903-1911
13. Fagiolini A., Frank E., Scott J.A., Turkin S., and Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 7 (2005) 424-430
14. Fagiolini A., Frank E., Turkin S., Houck P.R., Soreca I., and Kupfer D.J. Metabolic syndrome in patients with bipolar disorder. J. Clin. Psychiatry 69 (2008) 678-679
15. Fleischhacker W.W., Cetkovich-Bakmas M., De Hert M., Hennekens C.H., Lambert M., Leucht S., Maj M., McIntyre R.S., Naber D., Newcomer J.W., Olfson M., Osby U., Sartorius N., and Lieberman J.A. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J. Clin. Psychiatry 69 (2008) 514-519
16. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
17. Garcia-Portilla M.P., Saiz P.A., Benabarre A., Sierra P., Perez J., Rodriguez A., Livianos L., Torres P., and Bobes J. The prevalence of metabolic syndrome in patients with bipolar disorder. J. Affect. Disord. 106 (2008) 197-201
18. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
19. Hartz I., Njolstad I., and Eggen A.E. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromso study 2001. Eur. Heart J. 26 (2005) 2673-2680
20. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck Jr. P.E., Leverich G.S., Altshuler L., Denicoff K.D., Nolen W.A., Kupka R., Grunze H., Walden J., and Post R.M. Correlates of overweight and obesity in 644 patients with bipolar disorder. J. Clin. Psychiatry 63 (2002) 207-213
21. Newcomer J.W. Medical risk in patients with bipolar disorder and schizophrenia. J. Clin. Psychiatry 67 suppl 9 (2006) 25-30
22. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
23. Ösby U., Brand L., Correia N., Ekbom A., and Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58 (2007) 844-850
24. Salvi V., Albert U., Chiarle A., Soreca I., Bogetto F., and Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen. Hosp. Psych. 30 (2008) 318-323
25. Uçok A., Polat A., Bozkurt O., and Meteris H. Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry Clin. Neurosci. 58 (2004) 434-437
26. van Winkel R., De Hert M., Van Eyck D., Hanssens L., Wampers M., Scheen A., and Peuskens J. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 10 (2008) 342-348
27. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
28. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines (1992), WHO, Geneve
29. Yumru M., Savas H.A., Kurt E., Kaya M.C., Selek S., Savas E., Oral E.T., and Atagun I. Atypical antipsychotics related metabolic syndrome in bipolar patients. J. Affect. Disord. 98 (2007) 247-252